Key result
Clopidogrel plus aspirin for 14 days did not significantly change surface expression of cellular adhesion molecules or plasma markers of coagulation and fibrinolysis compared to aspirin alone.
Why the study?
Does clopidogrel added to aspirin improve markers of inflammation, hemostasis, and fibrinolysis in patients with chronic angina pectoris?
RCT (n=42)
Double-blind
Randomized
Does clopidogrel added to aspirin improve markers of inflammation, hemostasis, and fibrinolysis in patients with chronic angina pectoris?
Adding clopidogrel to aspirin for 14 days does not significantly alter surrogate markers of inflammation, hemostasis, or fibrinolysis in patients with chronic angina pectoris.
Answers are grounded in this paper and cite their sources.
Clopidogrel added to aspirin does not improve these surrogate markers in chronic angina; confirms no short-term pleiotropic benefit on inflammation or hemostasis.
BACKGROUND: The interaction among inflammation, Hemostasis, and fibrinolysis plays a major role in the genesis of coronary artery disease (CAD). The aim of the study was to compare the effect of clopidogrel plus aspirin versus aspirin alone on cellular adhesion molecules on leukocytes, soluble adhesion molecules, and molecular markers of coagulation and fibrinolysis in patients with CAD. METHODS: In this randomized, placebo-controlled, and double-blind study, 42 patients with chronic angina pectoris were included. All patients were treated with aspirin (ASA). Twenty-three patients received clopidogrel additionally (75 mg/day with a 300-mg loading dose) for 14 days. Nineteen patients received placebo additionally. Soluble adhesion molecules (sICAM-1, sVCAM-1, sP-selectin), surface expression of CD54, CD11a, CD11b, CD40, CD40L, CD41, CD42b, and CD62L on lymphocytes, monocytes, and neutrophils, and markers of hemostasis and fibrinolysis (TAT, PAP, D-dimers) were measured. RESULTS: In the ASA + clopidogrel group, no change in surface expression of cellular adhesion molecules on leukocytes and on plasma levels of sICAM-1, sVCAM-1, sP-selectin, TAT, PAP, and D-dimers was detectable. CONCLUSIONS: Clopidogrel plus aspirin for 2 weeks did not result in a detectable benefit versus sole aspirin therapy regarding cellular adhesion molecules on leukocytes, plasma markers of coagulation, fibrinolysis, and soluble adhesion molecules in patients with CAD.
No takes yet. Share an insight, caveat, or question.
Walter et al. (2008) conducted an RCT in Coronary artery disease / Chronic angina pectoris (n=42). Clopidogrel plus aspirin vs. Aspirin alone (plus placebo) was evaluated on Cellular adhesion molecules on leukocytes, soluble adhesion molecules, and molecular markers of coagulation and fibrinolysis. Clopidogrel plus aspirin for 14 days did not significantly change surface expression of cellular adhesion molecules or plasma markers of coagulation and fibrinolysis compared to aspirin alone.
Synapse has enriched 10 related papers. Consider them for comparative context: